185 related articles for article (PubMed ID: 21271549)
1. [Memantine: the value of combined therapy].
Molinuevo JL
Rev Neurol; 2011 Jan; 52(2):95-100. PubMed ID: 21271549
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of memantine in the treatment of Alzheimer's disease].
Molinuevo Guix JL; Lladó Plarrumaní A
Neurologia; 2005 Dec; 20(10):686-91. PubMed ID: 16317590
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
Geerts H; Grossberg GT
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
[TBL] [Abstract][Full Text] [Related]
4. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Tariot PN
J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
[TBL] [Abstract][Full Text] [Related]
5. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
6. [New options for the pharmacotherapy of Alzheimer's disease after the registration of memantine?].
Frölich L; Schmitt B; Calabrese P; Diener H; Förstl H; Gertz HJ; Hallauer JF; Hampel H; Ihl R; Rieke K; Riepe M; Supprian T
Dtsch Med Wochenschr; 2005 Feb; 130(8):408-12. PubMed ID: 15717252
[No Abstract] [Full Text] [Related]
7. Alzheimer's disease and the glutamate NMDA receptor.
Doraiswamy PM
Psychopharmacol Bull; 2003; 37(2):41-9. PubMed ID: 14566213
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
9. [Newly approved drugs for Alzheimer disease: effectiveness and limitation].
Yanagisawa K
Brain Nerve; 2011 Aug; 63(8):863-8. PubMed ID: 21817177
[TBL] [Abstract][Full Text] [Related]
10. Domain-specific improvement of cognition on memantine in patients with Alzheimer's disease treated with rivastigmine.
Riepe MW; Adler G; Ibach B; Weinkauf B; Tracik F; Gunay I
Dement Geriatr Cogn Disord; 2007; 23(5):301-6. PubMed ID: 17356273
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32).
Olin JT; Bhatnagar V; Reyes P; Koumaras B; Meng X; Brannan S
Int J Geriatr Psychiatry; 2010 Apr; 25(4):419-26. PubMed ID: 19670390
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Alzheimer's disease and future approaches].
Forette F; Hauw JJ
Therapie; 2010; 65(5):429-37. PubMed ID: 21144478
[TBL] [Abstract][Full Text] [Related]
14. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse.
Parsons CG; Stöffler A; Danysz W
Neuropharmacology; 2007 Nov; 53(6):699-723. PubMed ID: 17904591
[TBL] [Abstract][Full Text] [Related]
15. Drugs for Alzheimer's disease.
Cranwell-Bruce LA
Medsurg Nurs; 2010; 19(1):51-3. PubMed ID: 20336985
[No Abstract] [Full Text] [Related]
16. Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.
Feldman HH; Schmitt FA; Olin JT;
Alzheimer Dis Assoc Disord; 2006; 20(4):263-8. PubMed ID: 17132971
[TBL] [Abstract][Full Text] [Related]
17. Rationalizing therapeutic approaches in Alzheimer's disease.
Grossberg GT
CNS Spectr; 2005 Nov; 10(11 Suppl 18):17-21. PubMed ID: 16273026
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
Bullock R
Alzheimer Dis Assoc Disord; 2006; 20(1):23-9. PubMed ID: 16493232
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of memantine.
Johnson JW; Kotermanski SE
Curr Opin Pharmacol; 2006 Feb; 6(1):61-7. PubMed ID: 16368266
[TBL] [Abstract][Full Text] [Related]
20. [Memantine brakes Alzheimer's dementia. The NMDA antagonist is effective in severe cases, too].
MMW Fortschr Med; 2003 May; 145 Suppl 2():21. PubMed ID: 14579479
[No Abstract] [Full Text] [Related]
[Next] [New Search]
